Madrigal Pharmaceuticals to Participate in the H.C. Wainwright & Co. 8th Annual MASH Investor Conference
Madrigal Pharmaceuticals (Nasdaq: MDGL) has announced its participation in the H.C. Wainwright 8th Annual MASH Virtual Investor Conference. The event will feature a fireside chat scheduled for 2:00 P.M. ET on Monday, Oct. 7, 2024. The session will be webcast live and can be accessed through a provided link or via Madrigal's Investor Relations Events page. A replay of the webcast will be available after the event.
Madrigal Pharmaceuticals (Nasdaq: MDGL) ha annunciato la sua partecipazione alla 8ª Conferenza Virtuale per Investitori MASH Annuale di H.C. Wainwright. L'evento includerà un fireside chat programmato per le 14:00 ET di lunedì 7 ottobre 2024. La sessione sarà trasmessa in diretta e sarà accessibile tramite un link fornito o attraverso la pagina eventi delle relazioni con gli investitori di Madrigal. Una registrazione della trasmissione sarà disponibile dopo l'evento.
Madrigal Pharmaceuticals (Nasdaq: MDGL) ha anunciado su participación en la 8ª Conferencia Virtual de Inversores MASH Anual de H.C. Wainwright. El evento contará con un fireside chat programado para las 2:00 P.M. ET del lunes 7 de octubre de 2024. La sesión se transmitirá en vivo y se podrá acceder a través de un enlace proporcionado o a través de la página de Eventos de Relaciones con Inversores de Madrigal. Una repetición de la transmisión estará disponible después del evento.
마드리갈 제약회사 (Nasdaq: MDGL)가 H.C. 웨인라이트 제8회 연례 MASH 가상 투자자 회의에 참가한다고 발표했습니다. 이 행사에는 파이어사이드 채팅이 2024년 10월 7일 월요일 오후 2시 ET에 예정되어 있습니다. 세션은 실시간으로 웹캐스트되며 제공된 링크 또는 마드리갈의 투자자 관계 이벤트 페이지를 통해 접근할 수 있습니다. 행사 후 웹캐스트의 재생도 가능합니다.
Madrigal Pharmaceuticals (Nasdaq: MDGL) a annoncé sa participation à la 8ème Conférence Virtuelle Annuelle pour Investisseurs MASH de H.C. Wainwright. L'événement comprendra un fireside chat prévu pour lundi 7 octobre 2024 à 14h00 ET. La session sera diffusée en direct et pourra être accessible via un lien fourni ou via la page Événements des Relations Investisseurs de Madrigal. Un replay du webcast sera disponible après l'événement.
Madrigal Pharmaceuticals (Nasdaq: MDGL) hat seine Teilnahme an der 8. Jährlichen Virtuellen Investorenkonferenz MASH von H.C. Wainwright angekündigt. Die Veranstaltung wird ein Fireside Chat beinhalten, der für Montag, den 7. Oktober 2024 um 14:00 Uhr ET geplant ist. Die Sitzung wird live übertragen und kann über einen bereitgestellten Link oder über die Investor Relations-Eventseite von Madrigal aufgerufen werden. Eine Wiederholung des Webcasts wird nach der Veranstaltung verfügbar sein.
- None.
- None.
CONSHOHOCKEN, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced the company will participate in a fireside chat at the H.C. Wainwright 8th Annual MASH Virtual Investor Conference at 2:00 P.M. ET on Monday, Oct. 7, 2024.
The fireside chat will be webcast live and may be accessed here or by visiting Madrigal’s website’s Investor Relations Events page. A replay of the webcast will be available after the event.
About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of NASH. For more information, visit www.madrigalpharma.com.
Investor Contact
Tina Ventura, IR@madrigalpharma.com
Media Contact
Christopher Frates, media@madrigalpharma.com
FAQ
When is Madrigal Pharmaceuticals participating in the H.C. Wainwright 8th Annual MASH Virtual Investor Conference?
How can I access the live webcast of Madrigal Pharmaceuticals' fireside chat at the H.C. Wainwright 8th Annual MASH Investor Conference?
Will there be a replay available for Madrigal Pharmaceuticals' fireside chat at the H.C. Wainwright 8th Annual MASH Investor Conference?